Award recordCONTRACT

EXELIXIS, INC.

PIID VA797P16A0025· VA Staff Offices· NAC PHARMACEUTICALS (36E797)· 6505 · DRUGS AND BIOLOGICALS· FY2016· $0 net obligations· UEI R47FPKTS9T63· CA

Description

PRODUCT DELETION BPA CANCELLATION

Base award description: BPA FOR COMETRIQ CAPSULES

First action · last action
2016-09-14 · 2017-05-15
Transactions
3
First transaction's obligation
$0
Base + all options value (sum of deltas)
$500,000
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D60634
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$1$0Base award · 2016-09-14 · this action $0 · running total $0Modification P00001 · 2016-12-28 · this action $0 · running total $0Modification P00002 · 2017-05-15 · this action $0 · running total $0
  • Base2016-09-14+$0= $0
  • Mod P000012016-12-28+$0= $0
  • Mod P000022017-05-15+$0= $0
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2016-09-14+$0$0BPA FOR COMETRIQ CAPSULES
Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2016-12-28+$0$02017 PL UPDATES
Mod P00002· LEGAL CONTRACT CANCELLATION2017-05-15+$0$0PRODUCT DELETION BPA CANCELLATION

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI R47FPKTS9T63)

AwardOffice · PSC / listingNet obligationsFY
36F79722D0147NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2022
VA26117F0396261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS$76,355FY2017
VA26117F0347261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS$6,925FY2017
VA26117F0102261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS$6,925FY2017
VA25817J0101258-NETWORK CNTRCT OFF 22G (36C258) · 6505 · DRUGS AND BIOLOGICALS$6,875FY2017
VA26317J0003618-MINNEAPOLIS VA MED CTR (00618) · 6505 · DRUGS AND BIOLOGICALS$13,750FY2017

Other recipients under 6505 from NAC PHARMACEUTICALS (36E797) (most recent first)

AwardRecipientOfficeNet obligationsFY
36E79726A0025CHIESI USA INCNAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0024NEUROTECH PHARMACEUTICALS, INCNAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0023TAKEDA PHARMACEUTICALS AMERICA, INC.NAC PHARMACEUTICALS (36E797)$0FY2026
36E79726D0041GOLDEN STATE MEDICAL SUPPLY, INC.NAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0022AURINIA PHARMA US INCNAC PHARMACEUTICALS (36E797)$0FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_VA797P16A0025_3600 · retrieved 2026-09-26.